ED
BHF icon

Exane Derivatives’s Brighthouse Financial BHF Stock Holding History

Exane Derivatives’s Portfolio BHF Stock Details BHF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-196
Closed -$8.09K – 697
2018
Q2 		$8.09K Hold
196
– – ﹤0.01% 461
2018
Q1 		$9.85K Hold
196
– – ﹤0.01% 418
2017
Q4 		$11.5K Hold
196
– – ﹤0.01% 396
2017
Q3 		$11.9K Buy
+196
New +$11.2K ﹤0.01% 385

Other funds holding BHF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Exane Derivatives's BHF Position: Q3 2018 in Review

Exane Derivatives sold out of Brighthouse Financial (BHF) in Q3 2018, closing a stake of 196 shares — an estimated $8.09K sold.

Exane Derivatives first reported a position in BHF in Q3 2017 and held it in 4 quarters. The position peaked at $11.9K in Q3 2017. 498 funds tracked by Wall St. Rank hold BHF as of Q3 2018.

  • Exane Derivatives reported no remaining Brighthouse Financial position as of Q3 2018 after selling out during the quarter.
  • Exane Derivatives sold 196 Brighthouse Financial shares in Q3 2018, an estimated $8.09K.
  • Exane Derivatives first reported a position in Brighthouse Financial in Q3 2017 and held it in 4 quarters.
  • Exane Derivatives's Brighthouse Financial position peaked at $11.9K in Q3 2017.
  • 498 funds tracked by Wall St. Rank held Brighthouse Financial as of Q3 2018.

Based on Exane Derivatives's 13F filing for Q3 2018, filed 24 Oct 2018.